{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T05:28:42Z","timestamp":1789450122494,"version":"build-2803163510"},"reference-count":24,"publisher":"Elsevier BV","issue":"40","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/j.vaccine.2013.06.080","type":"journal-article","created":{"date-parts":[[2013,7,12]],"date-time":"2013-07-12T12:45:43Z","timestamp":1373633143000},"page":"4416-4420","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Impact of MenBvac, an outer membrane vesicle (OMV) vaccine, on the meningococcal carriage"],"prefix":"10.1016","volume":"31","author":[{"given":"Val\u00e9rie","family":"Delbos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludovic","family":"Lem\u00e9e","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"B\u00e9nichou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles","family":"Berthelot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ala-Eddine","family":"Deghmane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Philippe","family":"Leroy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estelle","family":"Houivet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhamed-Kheir","family":"Taha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Caron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl. 2","key":"10.1016\/j.vaccine.2013.06.080_bib0005","doi-asserted-by":"crossref","first-page":"B26","DOI":"10.1016\/j.vaccine.2011.12.032","article-title":"The changing and dynamic epidemiology of meningococcal disease","volume":"30","author":"Halperin","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.06.080_bib0010","unstructured":"European Medicines Agency. http:\/\/www.ema.europa.eu\/ema\/index.jsp?curl=pages\/medicines\/human\/medicines\/002333\/human_med_001614.jsp&mid=WC0b01ac058001d124."},{"issue":"2","key":"10.1016\/j.vaccine.2013.06.080_bib0015","doi-asserted-by":"crossref","first-page":"174","DOI":"10.4161\/hv.18500","article-title":"Bexsero: a multicomponent vaccine for prevention of meningococcal disease","volume":"8","author":"Gorringe","year":"2012","journal-title":"Hum Vaccine Immunother"},{"issue":"1","key":"10.1016\/j.vaccine.2013.06.080_bib0020","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/j.1574-6976.2006.00052.x","article-title":"Lessons from meningococcal carriage studies","volume":"31","author":"Caugant","year":"2007","journal-title":"FEMS Microbiol Rev"},{"issue":"5","key":"10.1016\/j.vaccine.2013.06.080_bib0025","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1086\/527401","article-title":"Impact of meningococcal serogroup C conjugate vaccines on carriage and herd immunity","volume":"197","author":"Maiden","year":"2008","journal-title":"J Infect Dis"},{"issue":"7385","key":"10.1016\/j.vaccine.2013.06.080_bib0030","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1136\/bmj.326.7385.365","article-title":"Herd immunity from meningococcal serogroup C conjugate vaccination in England: database analysis","volume":"326","author":"Ramsay","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2013.06.080_bib0035","series-title":"The 31st meeting of the european society for paediatric infectious diseases","article-title":"Impact of a quadrivalent conjugate (MENACWY-CRM) or a serogroup B (4CMenB) meningococcal vaccine on meningococcal carriage in english university students","author":"Read","year":"2013"},{"issue":"8775","key":"10.1016\/j.vaccine.2013.06.080_bib0040","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/0140-6736(91)91961-S","article-title":"Effect of outer membrane vesicle vaccine against group B meningococcal disease in Norway","volume":"338","author":"Bjune","year":"1991","journal-title":"Lancet"},{"issue":"34","key":"10.1016\/j.vaccine.2013.06.080_bib0045","doi-asserted-by":"crossref","first-page":"5059","DOI":"10.1016\/j.vaccine.2012.05.051","article-title":"Evolution of immune response against Neisseria meningitidis B:14:P1.7,16 before and after the outer membrane vesicle vaccine MenBvac","volume":"30","author":"Caron","year":"2012","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2013.06.080_bib0050","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S1473-3099(11)70027-5","article-title":"From tailor-made to ready-to-wear meningococcal B vaccines: longitudinal study of a clonal meningococcal B outbreak","volume":"11","author":"Caron","year":"2011","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2013.06.080_bib0055","doi-asserted-by":"crossref","DOI":"10.1007\/s10096-013-1897-6","article-title":"Meningococcal carriage during a clonal meningococcal B outbreak in France","author":"Delbos","year":"2013","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2013.06.080_bib0060","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1128\/JCM.39.4.1553-1558.2001","article-title":"Simultaneous detection of Neisseria meningitidis, Haemophilus influenzae, and Streptococcus pneumoniae in suspected cases of meningitis and septicemia using real-time PCR","volume":"39","author":"Corless","year":"2001","journal-title":"J Clin Microbiol"},{"issue":"Pt 1","key":"10.1016\/j.vaccine.2013.06.080_bib0065","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1099\/jmm.0.05032-0","article-title":"Detection and genotyping of meningococci using a nested PCR approach","volume":"52","author":"Diggle","year":"2003","journal-title":"J Med Microbiol"},{"issue":"1","key":"10.1016\/j.vaccine.2013.06.080_bib0070","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1574-6976.2006.00057.x","article-title":"Molecular typing of meningococci: recommendations for target choice and nomenclature","volume":"31","author":"Jolley","year":"2007","journal-title":"FEMS Microbiol Rev"},{"key":"10.1016\/j.vaccine.2013.06.080_bib0075","series-title":"Meningococcal vaccines methods and protocols","first-page":"81","article-title":"Outer membrane vasicle vaccines for meningococcal disease","author":"Frasch","year":"2001"},{"issue":"5","key":"10.1016\/j.vaccine.2013.06.080_bib0080","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1093\/jac\/dkl066","article-title":"Immunogenicity of meningococcal PBP2 during natural infection and protective activity of anti-PBP2 antibodies against meningococcal bacteraemia in mice","volume":"57","author":"Zarantonelli","year":"2006","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"10.1016\/j.vaccine.2013.06.080_bib0085","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0378-1097(03)00252-0","article-title":"A model of meningococcal bacteremia after respiratory superinfection in influenza A virus-infected mice","volume":"222","author":"Alonso","year":"2003","journal-title":"FEMS Microbiol Lett"},{"issue":"9","key":"10.1016\/j.vaccine.2013.06.080_bib0090","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/0264-410X(94)00037-N","article-title":"Efficacy, safety, and immunogenicity of a meningococcal group B (15:P1.3) outer membrane protein vaccine in Iquique, Chile. Chilean National Committee for Meningococcal Disease","volume":"13","author":"Boslego","year":"1995","journal-title":"Vaccine"},{"issue":"8814","key":"10.1016\/j.vaccine.2013.06.080_bib0095","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/0140-6736(92)92411-8","article-title":"\u201cHerd immunity\u201d and the meningococcal vaccine trial in Norway","volume":"340","author":"Bjune","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2013.06.080_bib0100","series-title":"Eighth international pathogenic neisseria conference","article-title":"Changes in carrier status of Neisseria meningitidis in teenagers during a group B outer membrane vaccination trial in Norway","author":"Rosenqvist","year":"1994"},{"issue":"1200","key":"10.1016\/j.vaccine.2013.06.080_bib0105","article-title":"Proceedings of the Meningococcal Vaccine Strategy World Health Organization satellite meeting, 10 March 2004, Auckland, New Zealand","volume":"117","author":"Sexton","year":"2004","journal-title":"N Z Med J"},{"issue":"4","key":"10.1016\/j.vaccine.2013.06.080_bib0110","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1086\/603552","article-title":"Fast tracking the vaccine licensure process to control an epidemic of serogroup B meningococcal disease in New Zealand","volume":"49","author":"Lennon","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2013.06.080_bib0115","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1017\/S0950268807009211","article-title":"Combined administration of serogroup B meningococcal vaccine and conjugated serogroup C meningococcal vaccine is safe and immunogenic in college students","volume":"136","author":"Holmes","year":"2008","journal-title":"Epidemiol Infect"},{"issue":"7","key":"10.1016\/j.vaccine.2013.06.080_bib0120","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/j.vaccine.2012.12.022","article-title":"Could the multicomponent meningococcal serogroup B vaccine (4CMenB) control Neisseria meningitidis capsular group X outbreaks in Africa?","volume":"31","author":"Hong","year":"2013","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13008906?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13008906?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,14]],"date-time":"2018-10-14T16:52:23Z","timestamp":1539535943000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X13008906"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":24,"journal-issue":{"issue":"40","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["S0264410X13008906"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2013.06.080","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of MenBvac, an outer membrane vesicle (OMV) vaccine, on the meningococcal carriage","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2013.06.080","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}